Vaccines for sexually transmitted diseases
著者
書誌事項
Vaccines for sexually transmitted diseases
Butterworths, 1989
- 統一タイトル
-
Vaccine
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
"Proceedings of the conference 'Vaccines for sexually transmitted diseases,' Oxford, UK, 5-7 April 1989, sponsored by the journal Vaccine, co-sponsored by the World Health Organization."
Includes bibliographical references
内容説明・目次
内容説明
One of the most disappointing aspects of medicine during the past 25 years has been the great increase in the incidence of infections due to sexually transmitted agents. This work aims to take stock of our actual knowledge on STD vaccine development and to outline directions for future research. The book identifies a need to make progress both in changing peoples sexual behaviour as well as providing safe and effective vaccine protection against STDs.
目次
- Part 1 Introduction: epidemiology
- immunological principles of vaccine design
- selection and suitability of adjuvants. Part 2 Gonorrhoea and candidiasis: problems and prospects for the development of a vaccine against gonorrhoea
- serum and vaginal fluid antibodies against the gonococcal major iron-regulated protein in women with pelvic inflamatory disease or uncomplicated infection
- D.651, an oral vaccine for the prevention of vulvovaginal candidiasis
- preparation and characterization of pilin synthetic peptide-MIRP conjugates as a potential vaccine for the prevention of gonococcal infections
- specificity of serum immunoglobulin G subclass response to gonorrhoea in women
- molecular biology of gonococcal porim protein P.I. Part 3 Chlamydia: immunity to chlamydial infections
- prevention of pulmonary and genital chlamydia infection by oral immunization
- stability and safety of a chlamydial live vaccine against enzootic abortion of ewes
- passive transfer experiments to study the protection against "chlamydia psittaci" infection of the mouse
- lymphocyte proliferation response to chlamydial antigens in human ocular chlamydial infections
- production and immunoanalysis of recombinant "E. Trachomatis" serovar D major outer membrane protein (MOMP). Part 4: Syphilis
- experimental syphilis vaccines - use of aroA salmonella typhimurium to deliver recombinant "treponema pallidum" antigens
- cellular and molecular approaches to the development of a vaccine for syphilis. Part 5 Hepatitis B: current and future hepatitis B vaccines
- development and clinical studies with a recombinant DNA hepatitis B vaccine
- ISCOMs (immune-stimulating complexes) and the presentation of HBsAg peptides. Part 6 Papillomaviruses: a vaccine to genital papillomaviruses - is it feasible?
- vaccination against polyoma - and papillomavirus-induced tumours using vaccinia recombinants expressing non-structural proteins. Part 7 Herpes simplex: Herpes simplex vaccines
- development of an HSV subunit vaccine
- poor immunogenicity as the reasons for the ineffectiveness of a glycoprotein subunit vaccine for genital herpes
- efficacy of yeast-derived glycoprotein B of herpes simplex virus on the development of herpetic lesion after intravaginal challenge with HSV type 2
- follow-up report on 101 subjects vaccinated with Skinner herpes vaccine
- the development of a subunit cytomegalovirus vaccine
- effect of HSV-1 antigen preparations derived using a Zwitterionic detergent on HSV-1 latency using a mouse model
- characterization of an HSV-1 subunit vaccine and its enhanced immunogenicity in the form of an immunostimulating comples (HSV-1 ISCOM) preparation
- (Part contents)
「Nielsen BookData」 より